Submit a manuscript Register Sign up for article alerts Contact us Support

About Cancer Cell International

Aims and scope | Open access | Article-processing charges | Indexing services | Publication and peer review process | Editorial policies | Citing articles in Cancer Cell International | Why publish your article in Cancer Cell International?

This page includes information about the aims and scope of Cancer Cell International, editorial policies, open access and article-processing charges, the peer review process and other information. For details of how to prepare and submit a manuscript through the online submission system, please see the instructions for authors.

Aims & scope

Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from work using cell culture techniques.

Much of cancer work relates to biological experiments in which cells are grown in vitro, in two- or three-dimensional systems. Such experiments have provided crucial data in many fields, from the chemoattraction of immune cells or blood vessel endothelial cells (angiogenesis), to measurements of effective doses of drugs, irradiation and other modalities. Cancer Cell International considers manuscripts that include animal work (in vivo) only if the work is a logical progression from previous work in vitro.

Manuscripts from countries where open access would be particularly beneficial (developing countries, the former Soviet States, as well as countries where English is not the native language) will be given full consideration, and help can be made available in such circumstances, through BioMedES.

As an established journal, Cancer Cell International publishes many interesting articles from all over the world. It serves a particular need where wide communication of data is required, especially from countries that have a lower profile than many Western countries in biomedical publishing.

Open access

All articles published by Cancer Cell International are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

Authors of articles published in Cancer Cell International are the copyright holders of their articles and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate the article, according to the BioMed Central copyright and license agreement.

Article-processing charges

Open access publishing is not without costs. Cancer Cell International therefore levies an article-processing charge of £1215/$1865/€1430 for each article accepted for publication. We routinely waive charges for authors from low-income countries. Generally, if the submitting author's institution is a Member the cost of the article-processing charge is covered by the membership, and no further charge is payable. In the case of authors whose institutions are Supporter Members, however, a discounted article-processing charge is payable by the author. For further details, see our article-processing charge page. A limited number of waivers for article-processing charges are also available at the editors' discretion, and authors wishing to apply for these waivers should contact the editors.

Indexing services

All articles published in Cancer Cell International are included in PubMed, the most widely used biomedical bibliographic database service, which is run by the US National Library of Medicine. Other bibliographic databases that index articles published in Cancer Cell International include:

  • Biological Abstracts
  • BIOSIS
  • CAS
  • Citebase
  • Embase
  • Google Scholar
  • Index Copernicus
  • OAIster
  • PubMed
  • PubMed Central
  • Science Citation Index Expanded
  • SCImago
  • Scirus
  • Scopus
  • SOCOLAR
  • Zetoc

The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature, and other digital archives including e-Depot (The Netherlands).

Cancer Cell International is tracked by Thomson Reuters (ISI)and has an Impact Factor of 1.97.

Publication and peer review process

Criteria for publication

Cancer Cell International considers the following types of articles:

Primary research articles: these articles should report substantial advances in the field of cancer cell biology.

Reviews: these should present an up-to-date survey of specialised areas in cancer cell biology.

Hypothesis: short articles presenting an untested original hypothesis backed solely by previously published results rather than any new evidence.

Peer-review policies

Cancer Cell International has a strict peer review policy. This maintains an appropriate standard for the journal. It is difficult in the modern frenetic scientific world to get busy scientists to comply with reviewing requirements for manuscripts, and within a reasonable time frame. However, we must all help each other in this regard and we aim to get manuscripts reviewed as quickly as possible. During submission we ask that you suggest 3 or 4 independent (not close colleagues) referees for your manuscript. We will also find an independent one, as well as an editorial colleague to check the manuscript after two reports has been received. The editor has the final decision in acceptance or rejection.

Edited by Denys Wheatley, Cancer Cell International is supported by an expert Editorial Board.

Authors will be able to check the progress of their manuscript through the submission system at any time by logging into My Cancer Cell International, a personalized section of the site.

Reprints

High-quality, bound reprints can be purchased for all articles published. Please see our reprints website for further information about ordering reprints.

Supplements

Cancer Cell International will consider supplements based on proceedings (full articles or meeting abstracts), reviews or research. All articles submitted for publication in supplements are subject to peer review. Published supplements are fully searchable and freely accessible online and can also be produced in print. All full length articles (proceedings, reviews or research articles) are indexed by PubMed. PubMed displays the title of the supplement only in the case of meeting abstract collections. For further information, please contact us.

Editorial policies

All manuscripts submitted to Cancer Cell International should adhere to BioMed Central's editorial policies.

Citing articles in Cancer Cell International

Articles in Cancer Cell International should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. Cancer Cell Int [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Cancer Cell Int 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Why publish your article in Cancer Cell International?

High visibility

Cancer Cell International's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. Articles that have been especially highly accessed are highlighted with a 'Highly accessed' graphic, which appears on the journal's contents pages and search results.

Speed of publication

Cancer Cell International offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles are published with their final citation immediately upon acceptance in a provisional PDF form. The article will subsequently be published in both fully browsable web form, and as a formatted PDF; the article will then be available through Cancer Cell International, BioMed Central and PubMed Central and will also be included in PubMed.

Flexibility

Online publication in Cancer Cell International gives authors the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other papers).

Promotion and press coverage

Articles published in Cancer Cell International are included in article alerts and regular email updates. Some may be included in abstract books mailed to academics and are highlighted on Cancer Cell International's pages and on the BioMed Central homepage.

In addition, articles published in Cancer Cell International may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Cancer Cell International. A list of articles recently press-released by journals published by BioMed Central is available here.

Authors of articles published in Cancer Cell International retain the copyright of their articles and are free to reproduce and disseminate their work (for further details, see the BioMed Central copyright and license agreement).

For further information about the advantages of publishing in a journal from BioMed Central, please click here.